MedTrace Logo

Study for Using Radiosurgery on Limited Metastases of Breast Cancer

NCT00167414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2018-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therapy, or chemotherapy alone or in any combination. A second purpose of this study is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to the quality of life while on this treatment.

Conditions

  • Breast Cancer, Metastatic

Interventions

PROCEDURE

Hypofractionated Stereotactic Body Radiation Therapy

Hypofractionated Stereotactic Body Radiation Therapy

RADIATION

Hypofractionated Stereotactic Body Radiation Therapy

Hypofractionated Stereotactic Body Radiation Therapy for treatment of limited metastases from breast cancer primary.

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Hong Zhang, MD · University of Rochester

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2016-11-01
Completion
2016-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167414 on ClinicalTrials.gov